Scientists have developed a subretinal implant that allows people with age-related macular degeneration (AMD) to read again under normal lighting conditions.
Author: Mikolaj Laszkiewicz
Mikolaj Laszkiewicz
An experienced journalist and editor passionate about new technologies, computers, and scientific discoveries. He strives to bring a unique perspective to every topic. A law graduate.
The American Medical Association (AMA) has launched the AMA Center for Digital Health and AI, an initiative designed to put physicians at the center of the creation, regulation, and implementation of digital and AI technologies in medicine.
On October 20, 2025, a global outage hit Amazon Web Services’ cloud infrastructure. The incident disrupted hundreds of popular apps and services, causing significant paralysis in some sectors.
Very few young adults — members of Generation Z — are taking part in clinical trials and health studies in the UK. Experts warn that this could have long-term consequences for their health.
Amazon One Medical has introduced a new pay-per-visit pediatric care service. Parents can now access text consultations starting at $29 and video visits from $49.
Finnish company Oura, known for its health-monitoring smart rings, has raised $900 million in a new funding round led by Fidelity Management & Research Company (FMR Co.). The deal brings Oura’s valuation to $11 billion.
Nvidia has announced that the DGX Spark, its new compact AI computer boasting a staggering 1-petaflop performance, is now available for order. Priced at $4,000, it’s designed to fit comfortably on a desk.
Scientists at the University of Massachusetts Amherst have developed the first artificial neuron capable of directly “communicating” with living cells — all without the need for any external signal amplification devices.
The U.S. Food and Drug Administration (FDA) has announced the most serious type of market recall (Class I) for Impella heart pump controllers manufactured by a company owned by Johnson & Johnson, citing discovered cybersecurity flaws.
The U.S. Senate has passed an amendment to the defense budget bill banning federal funding for projects involving Chinese biotechnology companies deemed a threat to national security.